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Recombinant capsid protein VP1 (rVP1) of foot-and-
mouth disease virus is a protein exhibiting potent cytotoxi-
city to a variety of cancer cells. We have recently found
that rVP1 is capable of decreasing cancer cell motility but
increasing macrophages motility. The underlying molecular
mechanism for such paradoxical effects of rVP1 on cancer
and immune cells are still largely unclear. Here, we showed
that the miRNA expression patterns in ovarian cancer
SKOV-3 cells and RAW264.7 macrophage cells were
distinctively different. rVP1 upregulated more let-7a in
SKOV-3 cells than in macrophages. Examination of the
trajectories and migration velocity of the cells with time-
lapse microscopy showed that let-7a was effective in inhi-
biting SKOV-3 cells migration as compared to scramble
control. Pre-treatment with antisense sequence of let-7a
blocked the inhibitory effects of not only let-7a but also
rVP1 on the migration of SKOV-3 cells. In comparison,
RAW264.7 cells which contain more constitutive let-7a
than SKOV-3 was not as sensitive as SKOV-3 to the inhibi-
tory effect of synthetic let-7a. RAW264.7 cells were selec-
tively induced by rVP1 to secrete MMP-9 to facilitate its
migration, whereas SKOV-3 cells were not. These results
thus demonstrated that rVP1 might differentially regulate
cell motility by inducing more let-7a or MMP-9 in cancer
and immune cells.
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